Wayne Blosser

1.4k total citations
19 papers, 637 citations indexed

About

Wayne Blosser is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Wayne Blosser has authored 19 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Genetics. Recurrent topics in Wayne Blosser's work include Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (3 papers) and Neuroblastoma Research and Treatments (3 papers). Wayne Blosser is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (3 papers) and Neuroblastoma Research and Treatments (3 papers). Wayne Blosser collaborates with scholars based in United States, Italy and Egypt. Wayne Blosser's co-authors include Louis F. Stancato, Michele Dowless, Darlene Barnard, Constance King, Mark S. Marshall, David A. Barda, Richard P. Beckmann, Jack Dempsey, Samuel McNeely and Jonathan Low and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Wayne Blosser

19 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wayne Blosser United States 15 464 310 95 69 55 19 637
Kimberly N. Smitheman United States 11 856 1.8× 345 1.1× 72 0.8× 47 0.7× 51 0.9× 11 1.0k
Stephen D. Eastman United States 5 506 1.1× 472 1.5× 75 0.8× 78 1.1× 41 0.7× 6 790
David L. Shattuck United States 7 384 0.8× 365 1.2× 96 1.0× 63 0.9× 37 0.7× 9 695
Shany Koren Switzerland 8 367 0.8× 320 1.0× 82 0.9× 194 2.8× 75 1.4× 9 622
Yogindra Persaud United States 6 619 1.3× 368 1.2× 151 1.6× 99 1.4× 79 1.4× 12 818
Madhavi Tadi United States 7 849 1.8× 429 1.4× 70 0.7× 85 1.2× 83 1.5× 7 1.0k
Evelyn Maczey Germany 8 438 0.9× 338 1.1× 35 0.4× 56 0.8× 100 1.8× 11 662
Eli Wallace United States 9 538 1.2× 296 1.0× 106 1.1× 67 1.0× 66 1.2× 16 697
Jong Wook Kim United States 5 389 0.8× 254 0.8× 95 1.0× 89 1.3× 104 1.9× 5 555
Satoko Yamamoto Japan 18 301 0.6× 213 0.7× 86 0.9× 148 2.1× 53 1.0× 35 648

Countries citing papers authored by Wayne Blosser

Since Specialization
Citations

This map shows the geographic impact of Wayne Blosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Blosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Blosser more than expected).

Fields of papers citing papers by Wayne Blosser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Blosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Blosser. The network helps show where Wayne Blosser may publish in the future.

Co-authorship network of co-authors of Wayne Blosser

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Blosser. A scholar is included among the top collaborators of Wayne Blosser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Blosser. Wayne Blosser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Blosser, Wayne, Jack Dempsey, Ann M. McNulty, et al.. (2020). A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib. Oncotarget. 11(3). 216–236. 13 indexed citations
2.
Lowery, Caitlin D., Wayne Blosser, Michele Dowless, et al.. (2019). Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy. Oncotarget. 10(53). 5523–5533. 14 indexed citations
3.
Dowless, Michele, Caitlin D. Lowery, Terry J. Shackleford, et al.. (2018). Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling. Clinical Cancer Research. 24(23). 6028–6039. 47 indexed citations
4.
Lowery, Caitlin D., Michele Dowless, Wayne Blosser, et al.. (2017). The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma. Clinical Cancer Research. 23(15). 4354–4363. 53 indexed citations
5.
Lowery, Caitlin D., Wayne Blosser, Michele Dowless, et al.. (2017). Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α. Clinical Cancer Research. 24(4). 847–857. 26 indexed citations
6.
May, Caitlin D., Richard P. Beckmann, Wayne Blosser, et al.. (2016). Abstract 2458: Targeting checkpoint kinase 1 (CHK1) with the small molecule inhibitor LY2606368 mesylate monohydrate in models of high-risk pediatric cancer yields significant antitumor effects. Cancer Research. 76(14_Supplement). 2458–2458. 1 indexed citations
7.
Vakana, Eliza, Susan E. Pratt, Wayne Blosser, et al.. (2016). LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 8(6). 9251–9266. 54 indexed citations
8.
King, Constance, Samuel McNeely, Darlene Barnard, et al.. (2015). LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. Molecular Cancer Therapeutics. 14(9). 2004–2013. 139 indexed citations
9.
Tate, Courtney M., Roberto Pallini, Eliza Vakana, et al.. (2015). A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology. PLoS ONE. 10(4). e0125697–e0125697. 14 indexed citations
10.
Blosser, Wayne, Eliza Vakana, Michelle L. Swearingen, et al.. (2014). A Method to Assess Target Gene Involvement in Angiogenesis In Vitro and In Vivo Using Lentiviral Vectors Expressing shRNA. PLoS ONE. 9(4). e96036–e96036. 4 indexed citations
11.
Tate, Courtney M., Wayne Blosser, Glenn F. Evans, et al.. (2013). LY2228820 Dimesylate, a Selective Inhibitor of p38 Mitogen-activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formation in Vitro and in Vivo. Journal of Biological Chemistry. 288(9). 6743–6753. 37 indexed citations
12.
King, Constance, Darlene Barnard, David A. Barda, et al.. (2013). Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor. Investigational New Drugs. 32(2). 213–226. 90 indexed citations
13.
Meier, Timothy I., Mark Uhlik, Sudhakar Chintharlapalli, et al.. (2011). Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization. Molecular Cancer Therapeutics. 10(11). 2168–2178. 31 indexed citations
14.
Sutherland, Jeffrey J., Jonathan Low, Wayne Blosser, et al.. (2011). A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators. Molecular Cancer Therapeutics. 10(2). 242–254. 26 indexed citations
15.
Low, Jonathan, Wayne Blosser, Michele Dowless, et al.. (2011). Knockdown of Ubiquitin Ligases in Glioblastoma Cancer Stem Cells Leads to Cell Death and Differentiation. SLAS DISCOVERY. 17(2). 152–162. 10 indexed citations
16.
Ma, Liandong, Baohui Zhao, Richard A. Walgren, et al.. (2010). Efficacy of LY2784544, a Small Molecule Inhibitor Selective for Mutant JAK2 Kinase, In JAK2 V617F-Induced Hematologic Malignancy Models. Blood. 116(21). 4087–4087. 16 indexed citations
17.
Low, Jonathan, et al.. (2009). Phenotypic Fingerprinting of Small Molecule Cell Cycle Kinase Inhibitors for Drug Discovery. PubMed. 3. 13–21. 19 indexed citations
18.
Low, Jonathan, Shuguang Huang, Wayne Blosser, et al.. (2008). High-content imaging characterization of cell cycle therapeutics through in vitro and in vivo subpopulation analysis. Molecular Cancer Therapeutics. 7(8). 2455–2463. 29 indexed citations
19.
Low, Jonathan, Shuguang Huang, Michele Dowless, et al.. (2007). High-Content Imaging Analysis of the Knockdown Effects of Validated siRNAs and Antisense Oligonucleotides. SLAS DISCOVERY. 12(6). 775–788. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly N. Smitheman Breakdown of academic impact, for papers by Stephen D. Eastman Breakdown of academic impact, for papers by David L. Shattuck Breakdown of academic impact, for papers by Shany Koren Breakdown of academic impact, for papers by Yogindra Persaud Breakdown of academic impact, for papers by Madhavi Tadi Breakdown of academic impact, for papers by Evelyn Maczey Breakdown of academic impact, for papers by Eli Wallace Breakdown of academic impact, for papers by Jong Wook Kim Breakdown of academic impact, for papers by Satoko Yamamoto
Rankless by CCL
2026